Literature DB >> 6872314

Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.

M Björkholm, G Holm, J Askergren, H Mellstedt.   

Abstract

Lymphocyte counts and functional competence of lymphocytes from arterial and venous splenic blood were studied in six patients with Hodgkin's disease subjected to splenectomy. One patient was untreated, four were tested after mantle field treatment and a sixth patient had a splenic relapse after total nodal radiotherapy. The percentage of E binding cells in splenic venous blood was lower than that of arterial blood though no significant differences were found in total lymphocyte or E binding cell counts. The spontaneous lymphocyte DNA synthesis was lower in venous than in arterial splenic lymphocytes in all patients. Pokeweed mitogen (PWM)-induced DNA synthesis was much lower in lymphocytes from splenic venous blood than in those from arterial blood in two patients and marginally decreased in another two. The pattern of concanavalin A response was similar to that of PWM. The elimination of lymphocytes over the spleen could not be related to the presence of lymphocytotoxic serum factors or to splenic weight or histologically verified tumour involvement. The results support the notion that some facets of the blood lymphocyte abnormalities in Hodgkin's disease may be explained by removal of functionally active lymphocyte subpopulations in the spleen. It is also concluded that spontaneously activated lymphoid cells are detained in the spleen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6872314      PMCID: PMC1536038     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  On the fate of DNA synthesizing lymphoid blood cells in Hodgkin's disease.

Authors:  P Schick; F Trepel; H Begemann
Journal:  Scand J Haematol       Date:  1975-03

2.  Reactivity of lymphocytes from primary neoplasms of lymphoid tissues.

Authors:  J J Twomey; A H Laughter; S Lazar; C C Douglass
Journal:  Cancer       Date:  1976-08       Impact factor: 6.860

3.  Persisting lymphocyte deficiences during remission in Hodgkin's disease.

Authors:  M Björkholm; G Holm; H Mellstedt
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

4.  Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease.

Authors:  J R Eltringham; H S Kaplan
Journal:  Natl Cancer Inst Monogr       Date:  1973-05

5.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

6.  Impaired in vitro lymphocyte transformation in Hodgkin's disease.

Authors:  E M Hersh; J J Oppenheim
Journal:  N Engl J Med       Date:  1965-11-04       Impact factor: 91.245

7.  Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.

Authors:  A M Bobrove; Z Fuks; S Strober; H S Kaplan
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

8.  Lymphocyte abnormalities in untreated patients with Hodgkin's disease.

Authors:  G Holm; H Mellstedt; M Björkholm; B Johansson; D Killander; R Sundblad; G Söderberg
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

9.  Immunologic profile of patients with cured Hodgkin's disease.

Authors:  M Bjorkholm; G Holm; H Mellstedt
Journal:  Scand J Haematol       Date:  1977-05

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.